Lin Ming Lee

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Singapore General Hospital(Current)

National Cancer Centre Singapore

Duke-NUS Medical School

Duke Medical Center

Lin Ming Lee is an author at Singapore General Hospital specializing in hypoxia-induced resistance, hypoxia-induced apoptosis resistance, and molecular oncology.

ORCID

Publications per year

2018–2022

Publications

The arginase inhibitor Nω−hydroxy−nor−arginine (nor−NOHA) induces apoptosis in leukemic cells specifically under hypoxic conditions but CRISPR/Cas9 excludes arginase 2 (ARG2) as the functional target

King Pan Ng, Aditi Manjeri, Lin Ming Lee et al. · PLoS ONE · 2018 · 14 citations · Full text

Medicine, Molecular Biology, Oncology +15

A novel network pharmacology approach for leukaemia differentiation therapy using Mogrify®

Lin Ming Lee, Eleni Christodoulou, Pavithra Shyamsunder et al. · Oncogene · 2022 · 10 citations

Medicine, Oncology, Pharmacology +11

1–2 of 2